SELLAS Life Sciences Group, Inc. Income Statement
SLS / Health Care|15 years of annual SEC 10-K data (FY2010-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 13.3% compound annual rate over the past 10 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $0 | $7.6M | $1.9M | $1.9M | $0 | - | - | - | - | $9.3M | $2.8M | $2.2M | $0 | - |
| Cost of Revenue | $0 | $0 | $200.0K | $0 | $0 | - | - | - | - | - | $1.4M | $520.0K | $0 | $0 | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | $2.4M | $1.8M | - | - |
| SG&A Expense | $12.4M | $13.9M | $11.3M | $9.6M | $9.6M | $9.9M | $12.8M | $15.1M | $4.6M | - | - | - | $46.3M | $8.6M | $8.8M |
| R&D Expense | $19.1M | $24.0M | $15.7M | $9.3M | $9.3M | $7.3M | $8.8M | $6.1M | $11.4M | $23.6M | $27.7M | $20.4M | $14.6M | $3.9M | $7.9M |
| Operating Income | -$31.5M | -$37.9M | -$25.3M | -$17.0M | -$17.0M | -$20.0M | - | -$23.0M | -$16.0M | -$34.2M | -$43.9M | -$28.5M | -$21.2M | -$12.5M | - |
| Interest Expense | - | - | $6.0K | $26.0K | - | $118.0K | -$266.0K | -$462.0K | - | - | - | - | - | - | - |
| Income Tax | $0 | $0 | -$237.0K | -$17.0K | -$17.0K | -$81.0K | -$1.4M | $253.0K | $1.0K | $365.0K | $0 | $1.1M | -$1.1M | - | - |
| Net Income | -$30.9M | -$37.3M | -$20.7M | -$16.8M | -$16.8M | -$19.3M | -$27.7M | -$23.8M | -$17.7M | -$63.9M | -$36.6M | -$10.5M | -$2.5M | -$11.5M | -$12.0M |
| EPS (Basic) | -$0.50 | -$2.13 | -$1.34 | -$2.11 | - | - | - | - | - | -$0.02 | -$0.11 | -$0.52 | -$0.02 | - | - |
| EPS (Diluted) | -$0.50 | -$2.13 | -$1.34 | -$2.11 | -$10.92 | - | - | - | -$6.13 | -$0.85 | -$0.56 | -$0.32 | - | - | - |
| Shares Outstanding | 61.2M | 21.0M | 15.9M | 14.3M | 5.1M | 2.6M | 261.5K | 2.3M | 8.1M | 109.4M | 109.4M | 82.9M | 62.5M | 36.3M | - |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | 85.7% | 80.6% | - | - |
| Operating Margin | - | - | -332.8% | -893.8% | -893.8% | - | - | - | - | - | -471.1% | -1036.0% | - | - | - |
| Profit Margin | - | - | -272.4% | -881.9% | -881.9% | - | - | - | - | - | -392.8% | -383.2% | -116.7% | - | - |